To further test the use of TRAIL as a therapeutic for colorectal cancers during pregnancy, HT29 cells were treated with these dual affinity liposomes under FSS in whole blood to better simulate the environment found in the circulation. The gene discussed is TNFSF10; the disease is colorectal cancer.